Summary
This document is a technical report detailing the properties and applications of Carbopol® polymers, specifically in the formulation of oral suspensions. It outlines the advantages of using these polymers as suspending agents, highlighting their ability to simplify manufacturing processes and enhance the dosing experience for pediatric and geriatric patients. The report presents various benefits of Carbopol® polymers, such as their customizable flavor options, reliable quality, and unique characteristics that contribute to patient-centric formulations. Additionally, it includes a case study on a shelf-stable paracetamol oral suspension, which demonstrates the polymers' effectiveness in maintaining stability and preventing sedimentation. The report emphasizes the polymers' manufacturing under CGMP in ISO:9001 certified facilities and their extensive testing for biocompatibility and safety, making them suitable for various applications in the pharmaceutical industry.
